West Pharmaceutical Services Inc (WST)
314.70
-1.80
(-0.57%)
USD |
NYSE |
Nov 04, 16:00
316.20
+1.50
(+0.48%)
After-Hours: 20:00
West Pharmaceutical Services Price to Book Value: 8.281 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 8.329 |
| October 31, 2024 | 8.103 |
| October 30, 2024 | 8.237 |
| October 29, 2024 | 8.379 |
| October 28, 2024 | 8.168 |
| October 25, 2024 | 8.103 |
| October 24, 2024 | 8.701 |
| October 23, 2024 | 7.538 |
| October 22, 2024 | 7.537 |
| October 21, 2024 | 7.567 |
| October 18, 2024 | 7.727 |
| October 17, 2024 | 7.604 |
| October 16, 2024 | 7.613 |
| October 15, 2024 | 7.667 |
| October 14, 2024 | 7.781 |
| October 11, 2024 | 7.769 |
| October 10, 2024 | 7.642 |
| October 09, 2024 | 7.548 |
| October 08, 2024 | 7.547 |
| October 07, 2024 | 7.651 |
| October 04, 2024 | 7.811 |
| October 03, 2024 | 7.832 |
| October 02, 2024 | 7.898 |
| October 01, 2024 | 7.898 |
| September 30, 2024 | 7.907 |
| Date | Value |
|---|---|
| September 27, 2024 | 8.755 |
| September 26, 2024 | 8.646 |
| September 25, 2024 | 8.539 |
| September 24, 2024 | 8.719 |
| September 23, 2024 | 8.635 |
| September 20, 2024 | 8.675 |
| September 19, 2024 | 8.761 |
| September 18, 2024 | 8.704 |
| September 17, 2024 | 8.329 |
| September 16, 2024 | 8.355 |
| September 13, 2024 | 8.464 |
| September 12, 2024 | 8.375 |
| September 11, 2024 | 8.512 |
| September 10, 2024 | 8.602 |
| September 09, 2024 | 8.503 |
| September 06, 2024 | 8.368 |
| September 05, 2024 | 8.454 |
| September 04, 2024 | 8.578 |
| September 03, 2024 | 8.562 |
| August 30, 2024 | 8.829 |
| August 29, 2024 | 8.862 |
| August 28, 2024 | 8.378 |
| August 27, 2024 | 8.520 |
| August 26, 2024 | 8.544 |
| August 23, 2024 | 8.524 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
6.053
Minimum
Mar 23 2020
17.05
Maximum
Sep 08 2021
10.37
Average
9.917
Median
Price to Book Value Benchmarks
| Repligen Corp | 3.934 |
| Perspective Therapeutics Inc | 2.395 |
| Retractable Technologies Inc | 0.2535 |
| Xtant Medical Holdings Inc | 1.635 |
| Catheter Precision Inc | 0.0979 |
Price to Book Value Related Metrics
| PE Ratio | 46.69 |
| PS Ratio | 8.099 |
| Price to Free Cash Flow | 72.44 |
| Price | 314.70 |
| Earnings Yield | 2.14% |
| Market Cap | 22.79B |
| Operating PE Ratio | 39.42 |
| Normalized PE Ratio | 45.28 |